ZINBRYTA
ZINBRYTA
Discontinued
DIN Number
02459620
Drug Class
Human
Market Date
Mar 30, 2017
Company
HC
Biogen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02459620
AIG Number0158650001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC01 DACLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DACLIZUMAB BETAActive
Strength: 150 MG / ML
Monograph: DACLIZUMAB BETA